I am long Affy since 4 months and I am one of those persons who is checking the newswire every minute to check if a buyout news or O reintroduction news is out.. In brief, knowing that Takeda must have already concluded the cause of the deaths and of the allergy, why aren't they buying Affy ? isnt it a good buy?
For Takeda buying AFFY is a good option especially given the potential of Royalty Payouts when the Drug is introduced.
You never know when they will call the shots. We individuals think totally differently and corporates think differently. For them give and take 100-200 MLN does not matter, they will do the right thing and at the right time. You need to hold the shares as and when the news hit the stand.
About others I don't care, I've been here for more than 3+ years and knew where i stand. I'm here because of Takeda's 100% involvement.
Takeda is the payer of Royalty Payouts under the Takeda $180M milestone/royalties agreement. Why would Takeda want to buy AFFY so it can pay itself? Why would Takeda want to buy AFFY when to do so means that it takes on AFFY's liabilities for the securities class action, shareholder derivative claims and AFFY officer litigation indemnification obligations? Doesn't make any financial sense at all.